RFK Jr. unilaterally gives the OK for some unapproved peptides.
Oh boy. This move refers to BPC-157, TB-500, Mots-C, KPV, epitalon, and semax. A document outlining the decision indicates that this seems to be the Health Secretary’s call, even though FDA scientists advised against it in July. This broadens access, but still requires a patient-specific prescription and adverse reporting. [Link: Kennedy to Allow Broad Use of Unapproved Peptide Injections | https://www.nytimes.com/2026/10/28/health/peptides-kennedy-fda.html | nytimes.com]
Oh boy. This move refers to BPC-157, TB-500, Mots-C, KPV, epitalon, and semax. A document outlining the decision indicates that this seems to be the Health Secretary’s call, even though FDA scientists advised against it in July. This broadens access, but still requires a patient-specific prescription and adverse reporting.
Sign in to see your notifications or create an account to join the conversation.
Gathered from external sources. Rights to this text belong to whoever originally published it.